Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Down-regulation of MIR-195 and...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Down-regulation of MIR-195 and MIR-497 from the MicroRNA cluster at chromosome 17p13.1 in papillary serous carcinoma of the peritoneum
Show other versions (1)
Bibliographic Details
Main Authors:
Flavin, R
,
Smyth, P
,
Ring, M
,
Russell, S
,
Laios, A
,
Toole, S
,
Li, J
,
Denning, K
,
Aherne, S
,
Martin, C
,
Sheppard, B
,
Lao, K
,
Sheils, O
,
O'Leary, J
Format:
Conference item
Published:
2008
Holdings
Description
Other Versions (1)
Similar Items
Staff View
Showing
1 - 1
results of
1
Show all versions (2)
Search Result 1
Down-regulation of MIR-195 and MIR-497 from the MicroRNA cluster at chromosome 17p13.1 in papillary serous carcinoma of the peritoneum
by
Flavin, R
,
Smyth, P
,
Ring, M
,
Russell, S
,
Laios, A
,
O'Toole, S
,
Li, J
,
Denning, K
,
Aherne, S
,
Martin, C
,
Sheppard, B
,
Lao, K
,
Sheils, O
,
O'Leary, J
Published 2008
Conference item
Show all versions (2)
Similar Items
Down-regulation of MIR-195 and MIR-497 from the MicroRNA cluster at chromosome 17p13.1 in papillary serous carcinoma of the peritoneum
by: Flavin, R, et al.
Published: (2008)
miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma.
by: Flavin, R, et al.
Published: (2009)
Differential microma expression in primary peritoneal serous carcinoma versus ovarian serous
by: O'Leary, J, et al.
Published: (2008)
Differential microrna expression in primary peritoneal serous carcinoma versus ovarian serous carcinoma
by: O'Leary, J, et al.
Published: (2008)
MIR-29B expression is associated with disease-free survival in ovarian serous carcinoma patients
by: Flavin, R, et al.
Published: (2008)